Ana Sofia Coroadinha has a Biochemistry degree and a PhD in Chemical Engineering (ITQB- NOVA). Since July 2009, she has been the head of Cell Line Development and Molecular Virology Lab at Animal Cell Technology Unit, iBET and ITQB-NOVA, Portugal. Her research interests focus on applied virology with the aim to provide therapeutic solutions for human healthcare through the use of recombinant virus. Focusing in the areas of gene therapy and vaccines, her research comprises the development of expression systems, development of cell substrates and cell lines, recombinant virus and viral particles engineering, and development of enabling tools for virus research.